Large, Independent

MolecuLight Inc. Taiwan Ontario

27.08.2025 - 12:14:16

Large Independent Randomized Controlled Trial Validates MolecuLight's Transformative Impact on Wound Debridement, Showing Improved Outcomes and Lower Costs

is a privately owned medical imaging company with a global presence that manufactures and commercializes the MolecuLight i:X® and DX® wound imaging devices. These are the only class II FDA-cleared point-of-care imaging devices for the real-time detection of elevated bacterial burden in wounds. They also provide accurate digital wound measurement for comprehensive wound management, supported by strong clinical evidence including over 100 peer-reviewed publications.

About Healtdeva Company Ltd.
Healtdeva Company Ltd. was established in 1992 and is based in Taipei, Taiwan. Healtdeva Company Ltd. is a trusted distributor of medical technologies and healthcare solutions, with a well-established network across hospitals, clinics, and retail pharmaceuticals, advanced wound care, infection control, and preventive health. Healtdeva Company partners with global innovators to bring cutting-edge medical solutions to the Taiwanese market, driving clinical adoption and commercial success through localized expertise and strategic channel integration.

MolecuLight logo

Photo - https://mma.prnewswire.com/media/2758647/MolecuLight_Large_Independent_Randomized_Controlled_Trial_Valida.jpg 
Logo - https://mma.prnewswire.com/media/2758646/MolecuLight_Large_Independent_Randomized_Controlled_Trial_Valida.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/large-independent-randomized-controlled-trial-validates-moleculights-transformative-impact-on-wound-debridement-showing-improved-outcomes-and-lower-costs-302539536.html

@ prnewswire.co.uk